| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
282.53(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$132.51 - $182.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 560 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
459,004 |
461,916 |
540,416 |
1,579,317 |
| Total Sell Value |
$81,195,771 |
$81,646,316 |
$93,320,391 |
$252,708,726 |
| Total People Sold |
9 |
9 |
9 |
14 |
| Total Sell Transactions |
10 |
11 |
13 |
37 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Burnside William H.l. |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,450 |
24,433 |
|
- |
|
| Roberts Rebecca B |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,450 |
11,203 |
|
- |
|
| Freyman Thomas C |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,450 |
124,226 |
|
- |
|
| Austin Roxanne S |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,450 |
35,933 |
|
- |
|
| Rapp Edward J |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,450 |
30,034 |
|
- |
|
| Waddell Frederick H |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,450 |
26,433 |
|
- |
|
| Hart Brett J |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,450 |
16,947 |
|
- |
|
| Alpern Robert J |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,450 |
32,992 |
|
- |
|
| Meyer Melody B |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,450 |
13,973 |
|
- |
|
| Sorg Elaine K. |
SVP, US COMMERCIAL OPERATIONS |
• – – |
2023-04-25 |
4 |
S |
$165.00 |
$1,011,450 |
D/D |
(6,130) |
35,330 |
|
10% |
|
| Sorg Elaine K. |
SVP, US COMMERCIAL OPERATIONS |
• – – |
2023-04-25 |
4 |
OE |
$144.54 |
$886,030 |
D/D |
6,130 |
41,460 |
|
- |
|
| Sorg Elaine K. |
SVP, US COMMERCIAL OPERATIONS |
• – – |
2023-04-17 |
4 |
S |
$161.64 |
$1,212,338 |
D/D |
(7,499) |
35,330 |
|
9% |
|
| Siatis Perry C |
EVP, GC AND SECRETARY |
• – – |
2023-04-03 |
4 |
S |
$160.00 |
$563,200 |
D/D |
(3,520) |
10,377 |
|
5% |
|
| Siatis Perry C |
EVP, GC AND SECRETARY |
• – – |
2023-04-03 |
4 |
OE |
$105.92 |
$372,838 |
D/D |
3,520 |
13,897 |
|
- |
|
| Sorg Elaine K. |
SVP, US COMMERCIAL OPERATIONS |
• – – |
2023-04-03 |
4 |
S |
$160.03 |
$2,400,770 |
D/D |
(15,002) |
42,829 |
|
5% |
|
| Sorg Elaine K. |
SVP, US COMMERCIAL OPERATIONS |
• – – |
2023-04-03 |
4 |
OE |
$93.50 |
$1,402,687 |
D/D |
15,002 |
57,831 |
|
- |
|
| Strom Carrie C |
SVP & PRES GLOBAL ALLERG AESTH |
• – – |
2023-03-05 |
4 |
D |
$156.06 |
$70,071 |
D/D |
(449) |
30,900 |
|
- |
|
| Gonzalez Richard A |
CHAIRMAN OF THE BOARD AND CEO |
• • – |
2023-03-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,550 |
643,794 |
|
- |
|
| Strom Carrie C |
SVP & PRES GLOBAL ALLERG AESTH |
• – – |
2023-03-02 |
4 |
D |
$155.27 |
$125,769 |
D/D |
(810) |
31,349 |
|
- |
|
| Buckbee Kevin K |
SVP, Controller |
• – – |
2023-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,163 |
|
-13% |
|
| Richmond Timothy J. |
EVP, CHIEF HR OFFICER |
• – – |
2023-03-01 |
4 |
S |
$153.08 |
$6,766,103 |
D/D |
(44,141) |
13,837 |
|
13% |
|
| Reents Scott T |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2023-03-01 |
4 |
S |
$153.06 |
$2,440,355 |
D/D |
(15,942) |
809 |
|
13% |
|
| Siatis Perry C |
EVP, GC AND SECRETARY |
• – – |
2023-03-01 |
4 |
S |
$153.06 |
$1,857,641 |
D/D |
(12,135) |
10,377 |
|
13% |
|
| Saleki-Gerhardt Azita |
EVP, OPERATIONS |
• – – |
2023-03-01 |
4 |
S |
$153.05 |
$5,714,215 |
D/D |
(36,990) |
189,849 |
|
13% |
|
| Saleki-Gerhardt Azita |
EVP, OPERATIONS |
• – – |
2023-03-01 |
4 |
OE |
$51.42 |
$1,387,826 |
D/D |
26,990 |
226,839 |
|
- |
|
641 Records found
|
|
Page 3 of 26 |
|
|
7.67 (4.58%) 
